Release kinetics of inflammatory biomarkers in a clinical model of acute myocardial infarction

Circulation Research

Volumn 116, Issue 5, 2015, Pages 867-875

  Liebetrau, Christoph ^a,b,c   Hoffmann, Jedrzej ^a,b   Dörr, Oliver ^c   Gaede, Luise ^a,b   Blumenstein, Johannes ^a,b   Biermann, Hannes ^a,b   Pyttel, Lukas ^a,b   Thiele, Peter ^a,b   Troidl, Christian ^a,b   Berkowitsch, Alexander ^a,b   Rolf, Andreas ^a,b   Voss, Sandra ^a,b   Hamm, Christian W ^a,b,c   Nef, Holger ^c   Möllmann, Helge ^a,b  

^a Kerckhoff Heart and Thorax Center   (Germany)

^b DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^c JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Acute myocardial infarction; Inflammation; Leukocytes

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CD40 LIGAND; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 6; IL6 PROTEIN, HUMAN; TROPONIN T;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CATHETER ABLATION; CELL SUBPOPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; HYPERTENSION; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; INFLAMMATION; KINETICS; LABORATORY TEST; LEUKOCYTE; MALE; MONOCYTOSIS; NEUTROPHIL COUNT; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; SERUM; TRANSCORONARY ABLATION OF SEPTAL HYPERTROPHY; BLOOD; CARDIOMYOPATHY, HYPERTROPHIC; HEART INFARCTION; HEART VENTRICLE SEPTUM; LEUKOCYTE COUNT; LEUKOCYTOSIS; MIDDLE AGED; MONOCYTE; NEUTROPHIL; PATHOLOGY; SECRETION (PROCESS); SECRETION RATE;

AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOMYOPATHY, HYPERTROPHIC; CD40 LIGAND; FEMALE; HEART SEPTUM; HUMANS; INFLAMMATION; INTERLEUKIN-6; KINETICS; LEUKOCYTE COUNT; LEUKOCYTOSIS; MALE; MIDDLE AGED; MONOCYTES; MYOCARDIAL INFARCTION; NEUTROPHILS; SECRETORY RATE; TROPONIN T;

EID: 84924415569     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.116.304653     Document Type: Article

References (50)

1. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet. 2006;367:1747-1757. doi:10.1016/S0140-6736(06)68770-9.
2. Mather AN, Fairbairn TA, Artis NJ, Greenwood JP, Plein S. Relationship of cardiac biomarkers and reversible and irreversible myocardial injury following acute myocardial infarction as determined by cardiovascular magnetic resonance. Int J Cardiol. 2013;166:458-464. doi:10.1016/j.ijcard.2011.11.004.
3. Ferroni P, Rosa A, Di Franco M, Palmirotta R, Guadagni F, Davì G, Bertazzoni G, Basili S. Prognostic significance of interleukin-6 measurement in the diagnosis of acute myocardial infarction in emergency department. Clin Chim Acta. 2007;381:151-156. doi:10.1016/j.cca.2007.03.002.
4. Varo N, de Lemos JA, Libby P, Morrow DA, Murphy SA, Nuzzo R, Gibson CM, Cannon CP, Braunwald E, Schönbeck U. Soluble CD40L: risk prediction after acute coronary syndromes. Circulation. 2003;108:1049-1052. doi:10.1161/01.CIR.0000088521.04017.13.
5. Heeschen C, Dimmeler S, Hamm CW, van den Brand MJ, Boersma E, Zeiher AM, Simoons ML; CAPTURE Study Investigators. Soluble CD40 ligand in acute coronary syndromes. N Engl J Med. 2003;348:1104-1111. doi:10.1056/NEJMoa022600.
6. Weber M, Rabenau B, Stanisch M, Nef HM, Möllmann H, Elsässer A, Mitrovic V, Heeschen C, Hamm C. Influence of sample type on soluble CD40 ligand assessment in patients with acute coronary syndromes. Thromb Res. 2007;120:811-814. doi:10.1016/j.thromres.2007.01.014.
7. Zairis MN, Adamopoulou EN, Manousakis SJ, Lyras AG, Bibis GP, Ampartzidou OS, Apostolatos CS, Anastassiadis FA, Hatzisavvas JJ, Argyrakis SK, Foussas SG; Biomarkers of Inflammation and Outcome in Acute Coronary Syndromes (BIAS) Investigators. The impact of hs C-reactive protein and other inflammatory biomarkers on long-term cardiovascular mortality in patients with acute coronary syndromes. Atherosclerosis. 2007;194:397-402. doi:10.1016/j.atherosclerosis.2006.08.008.
8. Hartford M, Wiklund O, Mattsson Hultén L, Persson A, Karlsson T, Herlitz J, Caidahl K. C-reactive protein, interleukin-6, secretory phospholipase A2 group IIA and intercellular adhesion molecule-1 in the prediction of late outcome events after acute coronary syndromes. J Intern Med. 2007;262:526-536. doi:10.1111/j.1365-2796.2007.01862.x.
9. Kukielka GL, Smith CW, Manning AM, Youker KA, Michael LH, Entman ML. Induction of interleukin-6 synthesis in the myocardium. Potential role in postreperfusion inflammatory injury. Circulation. 1995;92:1866-1875.
10. Sasayama S, Matsumori A, Kihara Y. New insights into the pathophysiological role for cytokines in heart failure. Cardiovasc Res. 1999;42:557-564.
11. Agorastos A, Hauger RL, Barkauskas DA, Moeller-Bertram T, Clopton PL, Haji U, Lohr JB, Geracioti TD Jr, Patel PM, Chrousos GP, Baker DG. Circadian rhythmicity, variability and correlation of interleukin-6 levels in plasma and cerebrospinal fluid of healthy men. Psychoneuroendocrinology. 2014;44:71-82. doi:10.1016/j.psyneuen.2014.02.020.
12. Suzuki K, Nakaji S, Yamada M, Liu Q, Kurakake S, Okamura N, Kumae T, Umeda T, Sugawara K. Impact of a competitive marathon race on systemic cytokine and neutrophil responses. Med Sci Sports Exerc. 2003;35:348-355. doi:10.1249/01.MSS.0000048861.57899.04.
13. Sano T, Tanaka A, Namba M, Nishibori Y, Nishida Y, Kawarabayashi T, Fukuda D, Shimada K, Yoshikawa J. C-reactive protein and lesion morphology in patients with acute myocardial infarction. Circulation. 2003;108:282-285. doi:10.1161/01.CIR.0000079173.84669.4F.
14. Hong MK, Mintz GS, Lee CW, Kim YH, Lee SW, Song JM, Han KH, Kang DH, Song JK, Kim JJ, Park SW, Park SJ. Comparison of coronary plaque rupture between stable angina and acute myocardial infarction: a three-vessel intravascular ultrasound study in 235 patients. Circulation. 2004;110:928-933. doi:10.1161/01.CIR.0000139858.69915.2E.
15. Otake H, Shite J, Shinke T, Watanabe S, Tanino Y, Ogasawara D, Sawada T, Hirata K, Yokoyama M. Relation between plasma adiponectin, high-sensitivity C-reactive protein, and coronary plaque components in patients with acute coronary syndrome. Am J Cardiol. 2008;101:1-7. doi:10.1016/j.amjcard.2007.07.041.
16. Müller II, Müller KA, Schönleber H, Karathanos A, Schneider M, Jorbenadze R, Bigalke B, Gawaz M, Geisler T. Macrophage migration inhibitory factor is enhanced in acute coronary syndromes and is associated with the inflammatory response. PLoS One. 2012;7:e38376. doi:10.1371/journal.pone.0038376.
17. Weber M, Bhatt DL, Brennan DM, Hankey GJ, Steinhubl SR, Johnston SC, Montalescot G, Mak KH, Fox KA, Easton DJ, Topol EJ, Hamm CW; CHARISMA Investigators. High-sensitivity C-reactive protein and clopidogrel treatment in patients at high risk of cardiovascular events: a substudy from the CHARISMA trial. Heart. 2011;97:626-631. doi:10.1136/hrt.2010.210419.
18. Arroyo-Espliguero R, Avanzas P, Cosín-Sales J, Aldama G, Pizzi C, Kaski JC. C-reactive protein elevation and disease activity in patients with coronary artery disease. Eur Heart J. 2004;25:401-408. doi:10.1016/j.ehj.2003.12.017.
19. Lee WW, Marinelli B, van der Laan AM, et al. PET/MRI of inflammation in myocardial infarction. J Am Coll Cardiol. 2012;59:153-163. doi:10.1016/j.jacc.2011.08.066.
20. Duan X, Ji B, Wang X, Liu J, Zheng Z, Long C, Tang Y, Hu S. Expression of microRNA-1 and microRNA-21 in different protocols of ischemic conditioning in an isolated rat heart model. Cardiology. 2012;122:36-43. doi:10.1159/000338149.
21. Clements P, Brady S, York M, Berridge B, Mikaelian I, Nicklaus R, Gandhi M, Roman I, Stamp C, Davies D, McGill P, Williams T, Pettit S, Walker D, Turton J; ILSI HESI Cardiac Troponins Working Group. Time course characterization of serum cardiac troponins, heart fatty acid-binding protein, and morphologic findings with isoproterenol-induced myocardial injury in the rat. Toxicol Pathol. 2010;38:703-714. doi:10.1177/0192623310374969.
22. Smithline HA, Thompson M, Moran C, Mader TJ. Can CK-MB and cTn-I be detected in the peripheral circulation within the first 10 min of acute coronary ischemia? Med Hypotheses. 2003;60:598-602.
23. Hoffmann J, Ospelt M, Troidl C, Voss S, Liebetrau C, Kim WK, Rolf A, Wietelmann A, Braun T, Troidl K, Sadayappan S, Barefield D, Hamm C, Nef H, Möllmann H. Sham surgery and inter-individual heterogeneity are major determinants of monocyte subset kinetics in a mouse model of myocardial infarction. PLoS One. 2014;9:e98456. doi:10.1371/journal.pone.0098456.
24. Liebetrau C, Möllmann H, Nef H, Szardien S, Rixe J, Troidl C, Willmer M, Hoffmann J, Weber M, Rolf A, Hamm C. Release kinetics of cardiac biomarkers in patients undergoing transcoronary ablation of septal hypertrophy. Clin Chem. 2012;58:1049-1054. doi:10.1373/clinchem.2011.178129.
25. Liebetrau C, Möllmann H, Dörr O, Szardien S, Troidl C, Willmer M, Voss S, Gaede L, Rixe J, Rolf A, Hamm C, Nef H. Release kinetics of circulating muscle-enriched microRNAs in patients undergoing transcoronary ablation of septal hypertrophy. J Am Coll Cardiol. 2013;62:992-998. doi:10.1016/j.jacc.2013.05.025.
26. Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, Shah PM, Spencer WHr, Spirito P, Ten Cate FJ, Wigle ED. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol. 2003;42:1687-1713.
27. Heeschen C, Dimmeler S, Hamm CW, Fichtlscherer S, Simoons ML, Zeiher AM; CAPTURE Study Investigators. Pregnancy-associated plasma protein-A levels in patients with acute coronary syndromes: comparison with markers of systemic inflammation, platelet activation, and myocardial necrosis. J Am Coll Cardiol. 2005;45:229-237. doi:10.1016/j.jacc.2004.09.060.
28. Khan SQ, Dhillon OS, O'Brien RJ, Struck J, Quinn PA, Morgenthaler NG, Squire IB, Davies JE, Bergmann A, Ng LL. C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) study. Circulation. 2007;115:2103-2110. doi:10.1161/CIRCULATIONAHA.106.685503.
29. Weber M, Bazzino O, Navarro Estrada JL, de Miguel R, Salzberg S, Fuselli JJ, Liebetrau C, Woelken M, Moellmann H, Nef H, Hamm C. Improved diagnostic and prognostic performance of a new high-sensitive troponin T assay in patients with acute coronary syndrome. Am Heart J. 2011;162:81-88. doi:10.1016/j.ahj.2011.04.007.
30. Kim SA, Rhee SJ, Shim CY, Kim JS, Park S, Ko YG, Choi D, Jang Y, Chung N, Ha JW. Prognostic value of N-terminal probrain natriuretic peptide level on admission in patients with acute myocardial infarction and preserved left ventricular ejection fraction. Coron Artery Dis. 2011;22:153-157. doi:10.1097/MCA.0b013e3283423622.
31. Berton G, Cordiano R, Palmieri R, Pianca S, Pagliara V, Palatini P. C-reactive protein in acute myocardial infarction: association with heart failure. Am Heart J. 2003;145:1094-1101. doi:10.1016/S0002-8703(03)00098-X.
32. Vigushin DM, Pepys MB, Hawkins PN. Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease. J Clin Invest. 1993;91:1351-1357. doi:10.1172/JCI116336.
33. Miedema MD, Conover CA, MacDonald H, Harrington SC, Oberg D, Wilson D, Henry TD, Schwartz RS. Pregnancy-associated plasma protein-A elevation in patients with acute coronary syndrome and subsequent atorvastatin therapy. Am J Cardiol. 2008;101:35-39. doi:10.1016/j.amjcard.2007.07.045.
34. Heeschen C, Hamm CW, Bruemmer J, Simoons ML. Predictive value of C-reactive protein and troponin T in patients with unstable angina: a comparative analysis. CAPTURE Investigators. Chimeric c7E3 AntiPlatelet Therapy in Unstable angina REfractory to standard treatment trial. J Am Coll Cardiol. 2000;35:1535-1542.
35. Baldus S, Heeschen C, Meinertz T, Zeiher AM, Eiserich JP, Münzel T, Simoons ML, Hamm CW; CAPTURE Investigators. Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation. 2003;108:1440-1445. doi:10.1161/01.CIR.0000090690.67322.51.
36. Shah SH, de Lemos JA. Biomarkers and cardiovascular disease: determining causality and quantifying contribution to risk assessment. JAMA. 2009;302:92-93. doi:10.1001/jama.2009.949.
37. Piira OP, Mustonen PE, Miettinen JA, Huikuri HV, Tulppo MP. Leisure time emotional excitement increases endothelin-1 and interleukin-6 in cardiac patients. Scand Cardiovasc J. 2012;46:7-15. doi:10.3109/14017431.2011.640709.
38. Reikeras O, Borgen P, Reseland JE, Lyngstadaas SP. Changes in serum cytokines in response to musculoskeletal surgical trauma. BMC Res Notes. 2014;7:128. doi:10.1186/1756-0500-7-128.
39. Dimitrow PP, Undas A, Bober M, Tracz W, Dubiel JS. Obstructive hypertrophic cardiomyopathy is associated with enhanced thrombin generation and platelet activation. Heart. 2008;94:e21. doi:10.1136/hrt.2007.126896.
40. Ivandic BT, Spanuth E, Haase D, Lestin HG, Katus HA. Increased plasma concentrations of soluble CD40 ligand in acute coronary syndrome depend on in vitro platelet activation. Clin Chem. 2007;53:1231-1234. doi:10.1373/clinchem.2007.085332.
41. Plaikner M, Peer A, Falkensammer G, Schmidauer C, Pechlaner C, Griesmacher A, Pachinger O, Mair J. Lack of association of soluble CD40 ligand with the presence of acute myocardial infarction or ischemic stroke in the emergency department. Clin Chem. 2009;55:175-178. doi:10.1373/clinchem.2008.114231.
42. Chia S, Nagurney JT, Brown DF, Raffel OC, Bamberg F, Senatore F, Wackers FJ, Jang IK. Association of leukocyte and neutrophil counts with infarct size, left ventricular function and outcomes after percutaneous coronary intervention for ST-elevation myocardial infarction. Am J Cardiol. 2009;103:333-337. doi:10.1016/j.amjcard.2008.09.085.
43. Meissner J, Irfan A, Twerenbold R, Mueller S, Reiter M, Haaf P, Reichlin T, Schaub N, Winkler K, Pfister O, Heinisch C, Mueller C. Use of neutrophil count in early diagnosis and risk stratification of AMI. Am J Med. 2011;124:534-542. doi:10.1016/j.amjmed.2010.10.023.
44. Basili S, Di Francoi M, Rosa A, Ferroni P, Diurni V, Scarpellini MG, Bertazzoni G. Absolute neutrophil counts and fibrinogen levels as an aid in the early diagnosis of acute myocardial infarction. Acta Cardiol. 2004;59:135-140.
45. Nahrendorf M, Pittet MJ, Swirski FK. Monocytes: protagonists of infarct inflammation and repair after myocardial infarction. Circulation. 2010;121:2437-2445. doi:10.1161/CIRCULATIONAHA.109.916346.
46. Tsujioka H, Imanishi T, Ikejima H, et al. Impact of heterogeneity of human peripheral blood monocyte subsets on myocardial salvage in patients with primary acute myocardial infarction. J Am Coll Cardiol. 2009;54:130-138. doi:10.1016/j.jacc.2009.04.021.
47. Swirski FK, Nahrendorf M, Etzrodt M, Wildgruber M, Cortez-Retamozo V, Panizzi P, Figueiredo JL, Kohler RH, Chudnovskiy A, Waterman P, Aikawa E, Mempel TR, Libby P, Weissleder R, Pittet MJ. Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science. 2009;325:612-616. doi:10.1126/science.1175202.
48. Tsou CL, Peters W, Si Y, Slaymaker S, Aslanian AM, Weisberg SP, Mack M, Charo IF. Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites. J Clin Invest. 2007;117:902-909. doi:10.1172/JCI29919.
49. Dewald O, Zymek P, Winkelmann K, Koerting A, Ren G, Abou-Khamis T, Michael LH, Rollins BJ, Entman ML, Frangogiannis NG. CCL2/Monocyte Chemoattractant Protein-1 regulates inflammatory responses critical to healing myocardial infarcts. Circ Res. 2005;96:881-889. doi:10.1161/01.RES.0000163017.13772.3a.
50. Antonopoulos AS, Margaritis M, Lee R, Channon K, Antoniades C. Statins as anti-inflammatory agents in atherogenesis: molecular mechanisms and lessons from the recent clinical trials. Curr Pharm Des. 2012;18:1519-1530.